Discussion
Stanford University medical researchers conducted a study on the correlation between the use of fertility drugs and ovarian cancer. Their study, published in the American Journal of Epidemiology, concludes that the use of the fertility drugs, Pergonal and Serophene, may increase the risk of ovarian cancer by three times. The lead author of the studies, Professor Alice Whittemore, stated, "Our finding in regard to fertility drugs is by no means certain. It is based on very small numbers and is really very tenuous."
FDA Commissioner David Kessler would like the infertility drug manufacturers to disclose the study findings and offer a warning on the drug packages. He notes, "Even though the epidemiology study is still preliminary, women have a right to know what is known. We're not looking to make more of this than there is."
If you were a manufacturer of one of the drugs, would you voluntarily disclose the study information?
6 years ago
3
Purchase the answer to view it

- drugs.docx
- turnitinreportt56373.pdf
- Why does Cowan believe it is important to examine technologies in the context of technological systems? What advantage does this broader perspective give to planners? Give a specific current technological example (not it the reading) in support of your an
- Discussion question
- Composition
- case study analysis"W4 Stoneworth Paving Company"
- Research the 4 competitive strategies and briefly describe them
- 150-500 word essay requirements in attachments
- Current issues assignments
- Jump Hospital currently allocates all maintenance department costs based on departmental square feet. However, the manager
- Unit 8 help
- Family law t